Correlation Between HANSOH PHARMAC and Takeda Pharmaceutical

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both HANSOH PHARMAC and Takeda Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HANSOH PHARMAC and Takeda Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between HANSOH PHARMAC HD 00001 and Takeda Pharmaceutical, you can compare the effects of market volatilities on HANSOH PHARMAC and Takeda Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HANSOH PHARMAC with a short position of Takeda Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of HANSOH PHARMAC and Takeda Pharmaceutical.

Diversification Opportunities for HANSOH PHARMAC and Takeda Pharmaceutical

0.1
  Correlation Coefficient

Average diversification

The 3 months correlation between HANSOH and Takeda is 0.1. Overlapping area represents the amount of risk that can be diversified away by holding HANSOH PHARMAC HD 00001 and Takeda Pharmaceutical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Takeda Pharmaceutical and HANSOH PHARMAC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HANSOH PHARMAC HD 00001 are associated (or correlated) with Takeda Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Takeda Pharmaceutical has no effect on the direction of HANSOH PHARMAC i.e., HANSOH PHARMAC and Takeda Pharmaceutical go up and down completely randomly.

Pair Corralation between HANSOH PHARMAC and Takeda Pharmaceutical

Assuming the 90 days horizon HANSOH PHARMAC HD 00001 is expected to generate 1.75 times more return on investment than Takeda Pharmaceutical. However, HANSOH PHARMAC is 1.75 times more volatile than Takeda Pharmaceutical. It trades about 0.16 of its potential returns per unit of risk. Takeda Pharmaceutical is currently generating about 0.01 per unit of risk. If you would invest  197.00  in HANSOH PHARMAC HD 00001 on November 8, 2024 and sell it today you would earn a total of  17.00  from holding HANSOH PHARMAC HD 00001 or generate 8.63% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

HANSOH PHARMAC HD 00001  vs.  Takeda Pharmaceutical

 Performance 
       Timeline  
HANSOH PHARMAC HD 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in HANSOH PHARMAC HD 00001 are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, HANSOH PHARMAC may actually be approaching a critical reversion point that can send shares even higher in March 2025.
Takeda Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Takeda Pharmaceutical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable fundamental indicators, Takeda Pharmaceutical is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

HANSOH PHARMAC and Takeda Pharmaceutical Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with HANSOH PHARMAC and Takeda Pharmaceutical

The main advantage of trading using opposite HANSOH PHARMAC and Takeda Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HANSOH PHARMAC position performs unexpectedly, Takeda Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Takeda Pharmaceutical will offset losses from the drop in Takeda Pharmaceutical's long position.
The idea behind HANSOH PHARMAC HD 00001 and Takeda Pharmaceutical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Complementary Tools

Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format